Virtualscopics Inc (VSCP) 4.04 $VSCP BioTelemetry, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Virtualscopics Inc (VSCP) 4.04 $VSCP

BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror", to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

BioTelemetry, Inc. Commences Previously Announced Tender Offer to Acquire VirtualScopics, Inc.
GlobeNewswire - Fri Apr 08, 3:05PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror", is commencing a cash tender offer to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics" (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock. The tender offer is being made pursuant to an Offer to Purchase, dated April 8, 2016, and in connection with the Agreement and Plan of Merger, dated March 25, 2016, among BioTelemetry, Offeror and VirtualScopics, which BioTelemetry and VirtualScopics previously announced on March 25, 2016.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

VirtualScopics, Inc. Cancels Conference Call Due To Recent Announcement Of The Definitive Agreement With BioTelemetry, Inc.
PR Newswire - Tue Mar 29, 7:50AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will not hold its conference call, or provide its webcast, previously scheduled for Wednesday, March 30, 2016 at 8:30 a.m. ET.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

VIRTUALSCOPICS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to BioTelemetry, Inc.
BusinessWire - Mon Mar 28, 2:54PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of VirtualScopics Inc. ("VirtualScopics" (NasdaqCM: VSCP) concerning the sale to BioTelemetry, Inc. Under the terms of the agreement, VirtualScopics common shareholders will only receive $4.05 per share, which is virtually no premium over the 52-week high and lower than at least one analyst's estimated value of $7.00 per share. Series A and Series B Convertible Preferred Stock shareholders will receive $336.30 per share and Series C-1 Convertible Preferred Stock holders will receive $920.00 per share. The tender offer is expected to commence on April 11, 2016 and will be open for a minimum of 20 business days.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of VirtualScopics Inc. to BioTelemetry, Inc. is Fair to Shareholders -- VSCP
ACCESSWIRE - Mon Mar 28, 9:14AM CDT
NEW YORK, NY / ACCESSWIRE / March 28, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
GlobeNewswire - Fri Mar 25, 10:30AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.
VSCP: 4.04 (+0.01), BEAT: 19.19 (+0.17)

VirtualScopics, Inc. Announces Amendment to Exclusive Marketing Agreement with PPD; Provides Additional Opportunities to Develop New Business Relationships
PR Newswire - Fri Jan 22, 8:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that it is amending its alliance agreement with PPD, a contract research organization (CRO), to eliminate the marketing exclusivity portion of the agreement, effective April 11, 2016. The agreement originally signed in 2010, which focused on oncology trials and was later expanded to include other therapeutic areas, restricted VirtualScopics and PPD from co-marketing with each other's competitors. Under the amended agreement, VirtualScopics and PPD will no longer be restricted by exclusive co-marketing. Going forward, they will continue to collaborate on joint imaging projects already underway, as well as those in the current backlog. In addition, they will continue to work together to win new business for their alliance.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Promotes Ronald Way to Chief Operating Officer
PR Newswire - Thu Dec 17, 12:02PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that Ronald Way, 60, has been promoted to chief operating officer (COO). Mr. Way joined VirtualScopics in January 2011 as director of operations and was promoted to vice president of operations in August 2014. Mr. Way will be responsible for leading all functions required to deliver superb clinical trial imaging solutions to the company's customers using regulatory compliant processes. Mr. Way has contributed to the increased customer loyalty retention rate over the past few years.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Reports 2015 Third Quarter Revenues Increase 18% From Prior Year Period And Company Achieves Positive Adjusted EBITDA
PR Newswire - Thu Oct 29, 3:01PM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter and nine months ended September 30, 2015.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. to Host Third Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, October 29, 2015
ACCESSWIRE - Wed Oct 28, 3:15PM CDT
ROCHESTER, NY / ACCESSWIRE / October 28, 2015 / VirtualScopics, Inc. (NASDAQ: VSCP) will host a conference call and live webcast to discuss the results of the third quarter 2015, to be held Thursday, October 29, 2015 at 4:30 PM Eastern Time.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Schedules Third Quarter 2015 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Wed Oct 14, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its third quarter 2015 financial results at the 4:00 p.m. ET market close on Thursday, October 29, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 4:30 p.m. ET that afternoon. The conference call and webcast information are as follows:
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Reports 2015 Second Quarter And Six Months Financial Results; Revenues Increase 14% From 2014 Second Quarter And 17% Above The Six Months Reported In 2014
PR Newswire - Tue Aug 11, 3:01PM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the second quarter and six months ended June 30, 2015. Revenues for the second quarter of 2015 rose 14% to $3,019,126 compared to revenues of $2,648,747 for the comparable prior year period. The company reported a net loss for the second quarter of 2015 of $546,992, or $0.20 loss per share, representing a 25% improvement from a net loss of $731,531, or $0.26 loss per share, reported in the second quarter of 2014. Revenues for the first half of 2015 rose 17% to $5,833,568 compared to revenues of $5,001,732 for the comparable prior year period. The company reported a net loss for the first half of 2015 of $1,099,664, or $0.40 loss per share, representing a 20% improvement from a net loss of $1,377,904, or $0.49 loss per share, reported in the first half of 2014.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Tuesday, August 11, 2015
ACCESSWIRE - Mon Aug 10, 3:16PM CDT
ROCHESTER, NY / ACCESSWIRE / August 10, 2015 / VirtualScopics, Inc. (NASDAQ: VSCP) will host a conference call and live webcast to discuss the results of the second quarter 2015, to be held Tuesday, August 11, 2015 at 4:30 PM Eastern Time.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Tue Jul 28, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that it will report its second quarter 2015 financial results at the 4:00 p.m. ET market close on Tuesday, August 11, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 4:30 p.m. ET that afternoon. Conference call, webcast and replay information is as follows:
VSCP: 4.04 (+0.01)

VirtualScopics and IXICO Alliance Receive Awards in Oncology and Neurodegenerative Disease
PR Newswire - Mon Jun 29, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, along with IXICO plc (AIM: IXI), the brain health company, announced today the alliance has been awarded contracts with two top 15 pharmaceutical companies, one in metastatic solid tumors and one in a rare neurodegenerative disease. IXICO's TrialTracker(TM) digital platform will be deployed in both studies to collect and manage imaging data and in the neurodegeneration study, IXICO's Assessa® digital technology will be used to analyze MRI data collected from patients.
VSCP: 4.04 (+0.01)

Lion Biotechnologies Names Molly Henderson Chief Financial Officer
GlobeNewswire - Mon Jun 08, 7:00AM CDT
Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced the appointment of Molly Henderson, CPA, as chief financial officer, effective immediately.
VSCP: 4.04 (+0.01), LBIO: 9.03 (+0.19)

VirtualScopics, Inc. Reports Voting Results At Annual Meeting Of Shareholders; All Board Seats Renewed
PR Newswire - Fri Jun 05, 10:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all three proposals contained in the company's 2015 proxy statement. The outcome of this morning's vote at the Annual Meeting of Shareholders is as follows:
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. To Webcast Annual Meeting Of Shareholders On June 2, 2015; Five Members Of Management To Provide Insight On Operational Excellence And Future Outlook
PR Newswire - Tue May 19, 10:39AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will webcast the 2015 Annual Meeting of Shareholders on Tuesday, June 2, 2015, beginning at 10:00 a.m. The meeting will be held at the Country Club of Rochester, 2935 East Avenue, Rochester, New York, and is open to all VirtualScopics shareholders. Information for this year's Annual Meeting, including the company's Annual Report, Form 10-K and Proxy Statement, can be found on the company's website, www.virtualscopics.com
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. To Present At The 2015 Marcum MicroCap Conference In New York City
PR Newswire - Wed May 13, 4:05PM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric Converse, president and chief executive officer, will be presenting at the Marcum MicroCap Conference, which will be held at the Grand Hyatt Hotel in New York City, on Wednesday, May 27, 2015 at 3:00 p.m. Mr. Converse will also be conducting one-on-one meetings with institutional investors that afternoon and on Thursday, May 28, 2015.
VSCP: 4.04 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 13

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 85

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 53

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 28

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 19

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 35

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 196

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Securities Fraud Investigation Casts Shadow on Driven Brands

Updated Category News Views 331

The Unfolding Drama Surrounding Driven Brands Out of nowhere, the waters are getting choppy for Driven Brands Holdings, and it’s not just a casual dip; more like a tsunami warning. Ademi LLP is cranking up the heat with an investigation into possible securities fraud that’s got investors scratching their heads and probably running for cover. What’s the Big Deal?...

Continue Reading
Info-Tech Research Group Expands Focus in Asia-Pacific Markets

Updated Category News Views 292

Info-Tech Research Group Expands Its Global Footprint Info-Tech Research Group has recently expanded its global presence by launching a new office in Singapore while significantly ramping up investments in New Zealand. This strategic move enables the firm to provide more localized, outcome-driven support to IT leaders throughout Southeast Asia and the Australia-New...

Continue Reading
Laramide Resources' Strategic Exploration Plans in Kazakhstan

Updated Category News Views 144

Exploration Drilling Plans by Laramide Resources Laramide Resources Ltd., a leading organization in uranium exploration, has identified multiple promising targets within its Chu-Sarysu Project. This initiative is set to take place in a mineral-rich area renowned for its potential to yield significant deposits of uranium and other valuable minerals like rare earth elements...

Continue Reading
Stravito Unveils AI Personas for Accelerated Market Insights

Updated Category News Views 311

Stravito Introduces AI Personas for Enhanced Market Positioning Stravito supports brands in rapidly validating their ideas using advanced AI technology. In a dynamic market environment, Stravito has launched an initiative designed to drastically improve the speed and reliability of idea testing for brands. This revolutionary tool, known as Stravito AI Personas, transforms...

Continue Reading
Duni Introduces Innovative Take-Away Series Boosting Sustainability

Updated Category News Views 245

Duni Introduces Innovative Take-Away Series Boosting Sustainability Duni is excited to unveil a fresh series of take-away packaging that represents a significant leap towards sustainability. The company has developed new packaging solutions that feature a grey plastic base, which can significantly enhance recycling efforts compared to traditional black plastic. This move...

Continue Reading